Norgine Ventures

Norgine Ventures operates as a specialized investment firm providing debt and debt-like financing solutions. Its core focus lies in empowering innovative, rapidly expanding companies within the European and UK healthcare and life sciences sectors. The firm’s approach involves offering tailored financial structures that support growth without diluting equity, catering to businesses with strong commercial propositions and clear pathways to market.

This venture arm emerged from Norgine, a long-established European specialist pharmaceutical company with over a century of operational history. Norgine Ventures was established to leverage the parent company's deep industry knowledge and financial strength, identifying and backing promising enterprises that align with Norgine's broader commitment to advancing patient care. The underlying insight was to bridge funding gaps for growing healthcare entities using alternative, flexible financing models.

Norgine Ventures primarily serves small to mid-sized innovative companies developing new products or services in pharmaceuticals, biotechnology, and medical technology. Its vision is to foster the development and commercialization of healthcare innovations by providing crucial capital, thereby contributing to a robust ecosystem of life science advancements. The firm looks to partner with these businesses as they navigate critical growth stages and expand their market reach.